1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Usage of synthesized oligonucleotides in molecular diagnostics and clinical applications
5.1.1.2. Advancements in oligonucleotide synthesis
5.1.2. Restraints
5.1.2.1. High treatment cost of oligonucleotides
5.1.3. Opportunities
5.1.3.1. Rising R&D expenditure and government investment in pharmaceutical and biotechnology research
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals and research support in underdeveloped countries
5.2. Cumulative Impact of COVID-19

6. Oligonucleotide Synthesis Market, by Product
6.1. Introduction
6.2. Equipment
6.3. Reagents
6.4. Synthesized Oligos
6.4.1. Synthesized Oligos Market, By Product
6.4.1.1. Intermediate-scale Synthesized Oligos
6.4.1.2. Large-scale Synthesized Oligos
6.4.1.3. Linkers & Adaptors
6.4.1.4. Oligonucleotide-based Drugs
6.4.1.5. Primers
6.4.1.6. Probes
6.4.2. Synthesized Oligos Market, By Type
6.4.2.1. Custom Oligos
6.4.2.2. Predesigned Oligos

7. Oligonucleotide Synthesis Market, by Application
7.1. Introduction
7.2. Diagnostic Applications
7.3. Research Applications
7.3.1. Gene Synthesis
7.3.2. Pcr
7.3.3. Qpcr
7.3.4. Sequencing
7.4. Therapeutic Applications
7.4.1. Cpg Oligonucleotide-based Therapies
7.4.2. Dna & Antisense Oligonucleotide-based Therapies
7.4.3. Rnai Oligonucleotide-based Therapies

8. Oligonucleotide Synthesis Market, by End User
8.1. Introduction
8.2. Academic Research Institutes
8.3. Diagnostic Laboratories
8.4. Hospitals
8.5. Pharmaceutical & Biotechnology Companies

9. Americas Oligonucleotide Synthesis Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Oligonucleotide Synthesis Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Oligonucleotide Synthesis Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Adtbio Agilent Technologies
13.2. Agilent Technologies, Inc.
13.3. Ajinomoto Bio-Pharma Services
13.4. Bio-synthesis Inc.
13.5. BioAutomation Corporation
13.6. Biogen Inc.
13.7. Danaher Corporation
13.8. Eurofins Genomics GmbH
13.9. Eurofins Genomics LLC
13.10. Eurogentec S.A.
13.11. Eurogentec SA
13.12. GE Healthcare Inc.
13.13. Genscript Corporation
13.14. GenScript, Inc.
13.15. Integrated DNA Technologies Inc.
13.16. Merck KGaA
13.17. Nitto Denko Avecia Inc
13.18. Sarepta Therapeutics Inc
13.19. Thermo Fisher Scientific Inc.
13.20. TriLink BioTechnologies, Incorporated

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2027
FIGURE 6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGOS, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGOS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
FIGURE 13. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGOS MARKET, BY PRODUCT, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY INTERMEDIATE-SCALE SYNTHESIZED OLIGOS, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY INTERMEDIATE-SCALE SYNTHESIZED OLIGOS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LARGE-SCALE SYNTHESIZED OLIGOS, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LARGE-SCALE SYNTHESIZED OLIGOS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LINKERS & ADAPTORS, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LINKERS & ADAPTORS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY OLIGONUCLEOTIDE-BASED DRUGS, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY OLIGONUCLEOTIDE-BASED DRUGS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRIMERS, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRIMERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PROBES, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PROBES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGOS MARKET, BY TYPE, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGOS MARKET, BY TYPE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM OLIGOS, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM OLIGOS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PREDESIGNED OLIGOS, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PREDESIGNED OLIGOS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 33. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2027
FIGURE 35. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2027 (USD MILLION)
FIGURE 36. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2027 (USD MILLION)
FIGURE 38. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENE SYNTHESIS, 2018-2027 (USD MILLION)
FIGURE 40. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PCR, 2018-2027 (USD MILLION)
FIGURE 42. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PCR, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY QPCR, 2018-2027 (USD MILLION)
FIGURE 44. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY QPCR, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SEQUENCING, 2018-2027 (USD MILLION)
FIGURE 46. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SEQUENCING, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD MILLION)
FIGURE 48. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 49. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CPG OLIGONUCLEOTIDE-BASED THERAPIES, 2018-2027 (USD MILLION)
FIGURE 50. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CPG OLIGONUCLEOTIDE-BASED THERAPIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 51. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA & ANTISENSE OLIGONUCLEOTIDE-BASED THERAPIES, 2018-2027 (USD MILLION)
FIGURE 52. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA & ANTISENSE OLIGONUCLEOTIDE-BASED THERAPIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 53. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNAI OLIGONUCLEOTIDE-BASED THERAPIES, 2018-2027 (USD MILLION)
FIGURE 54. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNAI OLIGONUCLEOTIDE-BASED THERAPIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 55. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 56. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2027
FIGURE 58. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2027 (USD MILLION)
FIGURE 59. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 60. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2027 (USD MILLION)
FIGURE 61. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 62. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 63. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 64. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2027 (USD MILLION)
FIGURE 65. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 66. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 88. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 89. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 90. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 91. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 92. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 93. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 94. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 95. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 96. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: FPNV POSITIONING MATRIX
FIGURE 97. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 98. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGOS, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGOS MARKET, BY PRODUCT, BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY INTERMEDIATE-SCALE SYNTHESIZED OLIGOS, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LARGE-SCALE SYNTHESIZED OLIGOS, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LINKERS & ADAPTORS, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY OLIGONUCLEOTIDE-BASED DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRIMERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PROBES, BY REGION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGOS MARKET, BY TYPE, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM OLIGOS, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PREDESIGNED OLIGOS, BY REGION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PCR, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY QPCR, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CPG OLIGONUCLEOTIDE-BASED THERAPIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA & ANTISENSE OLIGONUCLEOTIDE-BASED THERAPIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNAI OLIGONUCLEOTIDE-BASED THERAPIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 33. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 48. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 50. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 52. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 53. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 54. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 55. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 56. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 57. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 58. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 59. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 60. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 61. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 62. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 63. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: SCORES
TABLE 64. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BUSINESS STRATEGY
TABLE 65. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: PRODUCT SATISFACTION
TABLE 66. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: RANKING
TABLE 67. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 68. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: MERGER & ACQUISITION
TABLE 69. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 70. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 71. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: INVESTMENT & FUNDING
TABLE 72. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 73. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: LICENSE & PRICING

Companies Mentioned

Adtbio Agilent Technologies
Agilent Technologies, Inc.
Ajinomoto Bio-Pharma Services
Bio-synthesis Inc.
BioAutomation Corporation
Biogen Inc.
Danaher Corporation
Eurofins Genomics GmbH
Eurofins Genomics LLC
Eurogentec S.A.
Eurogentec SA
GE Healthcare Inc.
Genscript Corporation
GenScript, Inc.
Integrated DNA Technologies Inc.
Merck KGaA
Nitto Denko Avecia Inc
Sarepta Therapeutics Inc
Thermo Fisher Scientific Inc.
TriLink BioTechnologies, Incorporated